Courtney Fitzhugh
#35,416
Most Influential Person Now
American hematologist and scientist
Courtney Fitzhugh's AcademicInfluence.com Rankings
Courtney Fitzhughmedical Degrees
Medical
#473
World Rank
#647
Historical Rank
#191
USA Rank
Hematology
#56
World Rank
#62
Historical Rank
#14
USA Rank
Download Badge
Medical
Courtney Fitzhugh's Degrees
- Doctorate Medicine University of Pennsylvania
- PhD Molecular and Cellular Biology University of Pennsylvania
Why Is Courtney Fitzhugh Influential?
(Suggest an Edit or Addition)According to Wikipedia, Courtney D. Fitzhugh is an American hematologist-oncologist and scientist. She is a clinical researcher and head of the laboratory of early sickle cell mortality prevention at the National Heart, Lung, and Blood Institute.
Courtney Fitzhugh's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. (2014) (255)
- Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. (2009) (229)
- Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease (2009) (188)
- Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now. (2011) (128)
- At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT. (2017) (105)
- Enalapril and hydroxyurea therapy for children with sickle nephropathy (2005) (103)
- Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium? (2009) (96)
- Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study. (2019) (82)
- Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT. (2017) (72)
- Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait. (2002) (69)
- Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease. (2017) (63)
- Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions. (2014) (44)
- Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia (2015) (41)
- National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report. (2017) (39)
- Pain and opioid use after reversal of sickle cell disease following HLA‐matched sibling haematopoietic stem cell transplant (2019) (33)
- Measuring Deformability and Red Cell Heterogeneity in Blood by Ektacytometry. (2018) (32)
- Low-Dose Radiation Plus Rapamycin Promotes Long-Term Bone Marrow Chimerism (2005) (32)
- Baseline TP53 mutations in Adults with SCD developing Myeloid Malignancy following Hematopoietic Cell Transplantation. (2020) (31)
- Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution. (2018) (29)
- Losartan for the nephropathy of sickle cell anemia: A phase‐2, multicenter trial (2017) (28)
- Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapy. (2008) (28)
- Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine model (2013) (21)
- Hematopoietic progenitor cell mobilization is more robust in healthy African American compared to Caucasian donors and is not affected by the presence of sickle cell trait (2016) (20)
- Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease. (2020) (20)
- Transfusion-associated babesiosis with an atypical time course after nonmyeloablative transplantation for sickle cell disease. (2008) (19)
- The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia. (2017) (19)
- Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor. (2020) (18)
- Immunohaematological complications in patients with sickle cell disease after haemopoietic progenitor cell transplantation: a prospective, single-centre, observational study. (2017) (18)
- Measurements of red cell deformability and hydration reflect HbF and HbA2 in blood from patients with sickle cell anemia. (2017) (17)
- When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease. (2018) (17)
- Reversal of pre-capillary pulmonary hypertension in a patient with sickle cell anemia who underwent haploidentical peripheral blood stem cell transplantation (2017) (17)
- Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial. (2020) (16)
- Successful fertility restoration after allogeneic hematopoietic stem cell transplantation. (2014) (15)
- Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study. (2020) (15)
- Severe cardiac iron toxicity in two adults with sickle cell disease (2017) (14)
- American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation. (2021) (13)
- Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies. (2017) (13)
- Late effects of myeloablative bone marrow transplantation (BMT) in sickle cell disease (SCD). (2008) (11)
- A sensitive and rapid ultra high-performance liquid chromatography with tandem mass spectrometric assay for the simultaneous quantitation of cyclophosphamide and the 4-hydroxycyclophosphamide metabolite in human plasma. (2018) (11)
- Reversal of a rheologic cardiomyopathy following hematopoietic stem cell transplantation for sickle cell disease. (2019) (11)
- Alternative donor allogeneic hematopoietic cell transplantation for hemoglobinopathies. (2016) (11)
- Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease. (2021) (11)
- Neurocognitive functioning in symptomatic adults with sickle cell disease: A description and comparison with unaffected siblings (2019) (10)
- Dietary Iron Restriction Improves Markers of Disease Severity in Murine Sickle Cell Anemia. (2020) (10)
- Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor (2019) (9)
- Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease. (2017) (8)
- Gout and sickle cell disease: not all pain is sickle cell pain (2015) (7)
- Immunogenicity of HPV Quadrivalent Vaccine in Women after Allogeneic HCT is Comparable to Healthy Volunteers (2018) (6)
- Sleep disturbance in adults with sickle cell disease: relationships with executive and psychological functioning (2020) (6)
- Motivations and decision-making of adult sickle cell patients in high-risk clinical research. (2020) (6)
- Angioedema in patients treated with sirolimus and ACE inhibitor post hematopoietic SCT (2014) (5)
- Incidence of second cancers after allogeneic hematopoietic stem cell transplantation using reduced-dose radiation. (2009) (4)
- At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation (2016) (4)
- Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Patients with Severe Sickle Cell Disease (SCD) (2011) (4)
- Infusion of hemolyzed red blood cells within peripheral blood stem cell grafts in patients with and without sickle cell disease. (2012) (4)
- Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease ‐ could we strike while the liver is hard? (2019) (3)
- Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism. (2022) (3)
- Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor‐mobilized patients with sickle cell disease (2022) (3)
- Increased Rates of Rhabdomyolysis in Male Hematopoietic Cell Transplant Recipients Taking Sirolimus and Trimethoprim/Sulfamethoxazole. (2021) (2)
- Post-Transplant Cyclophosphamide Improves Engraftment in Patients with Sickle Cell Disease (SCD) and Severe Organ Damage who Undergo Haploidentical Peripheral Blood Stem Cell Transplantation (PBSCT) (2016) (2)
- Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma (2009) (2)
- Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease (2021) (2)
- Choice of Donor Source and Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Sickle Cell Disease (2019) (2)
- Post-Transplant Cyclophosphamide and Sirolimus Are Synergistic in Preventing Rejection and Inducing Stable Mixed Chimerism Independently of Regulatory T Cells. (2009) (1)
- Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC2) (2020) (1)
- Pain and Opioid Use after Reversal of Sickle Cell Disease Following Hematopoietic Stem Cell Transplant (2017) (1)
- Results of Alternative Donor Search in Adult Patients with Severe Sickle Cell Disease (SCD) Eligible for Hematopoietic Stem Cell Transplantation (HSCT). (2007) (1)
- Computer Algorithm‐Based Hydroxyurea Dosing Facilitates Titration to Maximum Tolerated Dose in Sickle Cell Anemia (2020) (1)
- Morbidity and Associated Sudden Death in Sickle Cell Disease. (2005) (1)
- A Multi-Center, Phase-2 Trial of Losartan for the Nephropathy of Sickle Cell Anemia (2016) (1)
- Incidence of Epstein-Barr Virus (EBV) Detection in the Blood, Pre-Emptive Therapy, and EBV-Posttransplantation Lymphoproliferative Disorder (EBV-PTLD) after Allogeneic Hematopoietic Cell Transplantation (HCT) across a Broad Range of HCT Approaches and All Graft Sources (2019) (1)
- Hematopoietic Progenitor Cell Mobilization In Response To G-CSF Is More Robust In Healthy African American Compared To Caucasian Donors (2013) (1)
- Post- transplant ovarian function in women with sickle cell disease (2018) (1)
- Allogeneic Transplant and Gene Therapy: Evolving Toward a Cure. (2022) (1)
- Renal Function Is Preserved after Hematopoietic Stem Cell Transplantation for Sickle Cell Disease (2020) (1)
- Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies (2022) (1)
- Fertility Preservation for Women with Sickle Cell Disease (SCD) (2015) (1)
- Thrombospondin-1, Platelet Factor 4, and Galectin-1 are Associated with Engraftment in Patients with Sickle Cell Disease Who Underwent Haploidentical HSCT. (2022) (1)
- Do the Eyes Reveal More Than Scleral Icterus in Sickle Cell Disease? (2015) (0)
- Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell disease. (2022) (0)
- Tu1539 - Vibration Controlled Elastography Predicts Severity of Portal Hypertension in Non Cirrhotic Portal Hypertension (2018) (0)
- Contents Vol. 41, 2015 (2015) (0)
- Sirolimus, Post–Transplant Cyclophosphamide, and CTLA4-Ig Maintain Stable Mixed Chimerism In a Mismatched Murine Model (2017) (0)
- Etiology of and Associations with Early Death in Adult Patients with Sickle Cell Disease At a Single Referral Institution. (2012) (0)
- Characterization of Early Lymphocytes Emerging After Nonmyeloablative Conditioning and Hematopoietic Stem Cell Transplant Supported with Sirolimus (2012) (0)
- Evaluation of regulatory immune cells that favor engraftment following haploidentical peripheral blood stem cell transplantation for sickle cell disease (2020) (0)
- Optimization of Autologous Hematopoietic Progenitor Stem Cell Apheresis Collection from Plerixafor-Mobilized Patients with Sickle Cell Disease (2021) (0)
- Percent Patient NK and T Cells at Day 28 Predict Graft Outcome after Haploidentical Hematopoietic Cell Transplant for Sickle Cell Disease (2022) (0)
- Peripheral Blood As a Source Of Cells For Regenerative Medicine Applications In Sickle Cell Disease (2013) (0)
- Low Dose Post-Transplant Cyclophosphamide and Sirolimus Combined with Lymphocyte Depletion in MHC-Mismatched Murine Allogeneic Hematopoietic Cell Transplantation Maintains Donor Myeloid Chimerism Levels Greater Than 20% (2023) (0)
- Nonmyeloablative conditioning employing busulfan and sirolimus permits donor-dominant stable chimerism in a murine model of haploidentical allogeneic stem cell transplantation (P2192) (2013) (0)
- A Novel Recombinant Eklf-GATA1 Fusion Protein Reduces Sickling of Erythrocytes Cultured from CD34+ Cells with Sickle Cell Disease (2016) (0)
- Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease (2023) (0)
- Reduction in vaso-occlusive events following stem cell transplantation in patients with sickle cell disease (2022) (0)
- Allogeneic hematopoietic cell transplants for sickle cell disease (2017) (0)
- Nonmyeloablative Hematopoietic Stem Cell Transplantation (HSCT) Improves Cardiac Function in Patients with Sickle Cell Disease (SCD) (2017) (0)
- Pulmonary Function before and after Hematopoietic Cell Transplant in People Living with Sickle Cell Disease (2022) (0)
- Nonmyeloablative Hematopoietic Stem Cell Transplantation Improves a Marker of Diastolic Dysfunction in Patients with Sickle Cell Disease (2014) (0)
- Assessment Of The Endocrine Function Of Patients With Sickle Cell Disease After Allogeneic Hematopoietic Stem Cell Transplantation (2013) (0)
- Neurocognitive Functioning in Adults Who Underwent Nonmyeloablative HLA-Matched Sibling Hematopoietic Stem Cell Transplant (SCT) for Sickle Cell Disease (SCD) (2016) (0)
- Progression of Albuminuria in Sickle Cell Anemia: A Multicenter, Longitudinal Study (2019) (0)
- Long-Term Cardiac Effects of Successful Non-Myeloablative HLA-Matched Sibling Transplants in Sickle Cell Disease (2021) (0)
- Characterization of Immune Cells Producing Regulatory Cytokines That Mediate Engraftment in Sickle Cell Disease Patients after Haploidentical Peripheral Blood Stem Cell Transplantation (2019) (0)
- National Institutes of Health Blood and Marrow Transplant LateEffects Initiative: The Healthcare Delivery Working Group Report (2017) (0)
- The e w e n g a d j o u r n a l of m e d i c i n e Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease (2009) (0)
- Immunohematologic Complications after Nonmyeloablative Hematopoietic Progenitor Cell Transplantation in Patients with Sickle Cell Disease (2016) (0)
- Characterization of lymphocytes emerging early after nonmyeloablative conditioning and hematopoietic stem cell transplant supported with sirolimus (P2186) (2013) (0)
- Pentostatin Plus Cyclophosphamide Decrease Graft Rejection in Nonmyeloablative Haploidentical Hematopoietic Cell Transplantation for Sickle Cell Disease (2022) (0)
- Topic 5: Sickle Cell Disease-Related Stem Cell Transplantation (2019) (0)
- Chronic Administration of Hydroxyurea (HU) and Outcomes in Patients with Sickle Cell Disease (SCD) at a Single Referral Institution (2014) (0)
- Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell Disease (2022) (0)
- Galactin-1 favors engraftment in sickle cell disease patients after haploidentical hematopoietic stem cell transplantation and in murine MHC-mismatched allotransplantation (2020) (0)
- sickle cell disease (SCD) Late effects of myeloablative bone marrow transplantation (BMT) in (2011) (0)
- Kinase ′ and Phosphatidylinositol 3 IL-10 in Murine Mast Cells : Role of STAT 6 Inhibition of Kit Expression by IL-4 and Yeatman II (1999) (0)
- Evaluation of Early Biomarkers Associated with Graft Rejection in Patients with Sickle Cell Disease Undergoing Haploidentical Hematopoietic Stem Cell Transplantation (2018) (0)
- Evaluation of a Conditioning Regimen of Post-Transplant Cyclophosphamide and Sirolimus with or without CTLA4-Ig in a Mismatched Murine Model (2019) (0)
- 362 - Development of Non-Cirrhotic Portal Hypertension Increases Mortality Risk in at Risk Populations (2018) (0)
- Nonmyeloablative Transplant for Sickle Cell Disease Does Not Lead to Kidney Dysfunction Post-HSCT (2021) (0)
- Thrombospondin-1, Platelet Factor 4, and Galectin-1 Are Associated with Engraftment in Patients with Sickle Cell Disease Who Underwent Haploidentical HSCT (2018) (0)
- Safety of liver biopsy in patients with sickle cell related liver disease: A single‐center experience (2022) (0)
- Response: young adults with sickle cell disease have more transplant options (2011) (0)
- Therapeutic Hydroxyurea Dosing Is Associated With Decreased Organ Damage and Longer Survival In Adults With Sickle Cell Anemia (2013) (0)
This paper list is powered by the following services:
Other Resources About Courtney Fitzhugh
What Schools Are Affiliated With Courtney Fitzhugh?
Courtney Fitzhugh is affiliated with the following schools:
